Is Dimenhydrinate registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 1 valid registration of Dimenhydrinate, including DIZINIL 50MG TAB (50 mg, Tablet, SAR 9.40).

Is Dimenhydrinate approved by the US FDA?

Drugs@FDA lists 9 application product lines for Dimenhydrinate, including DIMENHYDRINATE (Prescription); DIMENHYDRINATE (Discontinued); DIMENHYDRINATE (Discontinued); DIMENHYDRINATE (Discontinued); DIMENHYDRINATE (Discontinued).

Active substance

Dimenhydrinate

SFDA 2
US FDA 9
Health Canada 20

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
DIZINIL 50MG TAB	50 mg	Tablet · Oral use	20 Blister	SAR 9.40	Generic · OTC	Gulf Pharmaceutical Industries (Julphar)	Valid
VALONTAN TAB 100MG	100 mg	Tablet · Oral use	20 Blister	SAR 3.85	NCE · OTC	RECORDATI	Invalid · Not Marketed

Indications — CHI Daman Drug Formulary

HUMAN IMMUNODEFICIENCY VIRUS; NAUSEA AND VOMITING IN PREGNANCY; TUBERCULOSIS-SUPPORTIVE CARE; VERTIGO - MENIERE'S DISEASE; VERTIGO - MOTION SICKNESS; VIRAL GASTROENTERITIS

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
DIMENHYDRINATE	50MG/ML	injectable · injection	FRESENIUS KABI USA	Prescription	23 Jun 2004
DIMENHYDRINATE	12.5MG/4ML	liquid · oral	ALRA	Discontinued	31 May 1972
DIMENHYDRINATE	50MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	injectable · injection	WATSON LABS TEVA	Discontinued	29 Jan 1974
DIMENHYDRINATE	50MG/ML	injectable · injection	WYETH AYERST	Discontinued	18 Aug 1975
DIMENHYDRINATE	50MG/ML	injectable · injection	BAXTER HLTHCARE	Discontinued	13 Sep 1976
DIMENHYDRINATE	50MG/ML	injectable · injection	WATSON LABS	Discontinued	5 Jul 1977
DIMENHYDRINATE	50MG	tablet · oral	NEXGEN PHARMA INC	Discontinued	19 Dec 1977
DIMENHYDRINATE	50MG	tablet · oral	HEATHER	Discontinued
DIMENHYDRINATE	50MG	tablet · oral	WATSON LABS	Discontinued

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
ANTI-NAUSEANT	02241532	50 MG	TABLET · ORAL	VITA HEALTH PRODUCTS INC
ANTI-NAUSEANT LIQUID GELS	02493004	50 MG	CAPSULE · ORAL	VITA HEALTH PRODUCTS INC
CONFAB DIMENHYDRINATE 100 MG	00392545	100 MG	SUPPOSITORY · RECTAL	LABORATOIRES CONFAB INC
CONFAB DIMENHYDRINATE 50 MG	00392553	50 MG	SUPPOSITORY · RECTAL	LABORATOIRES CONFAB INC
DIMENHYDRINATE INJECTION USP	00392537	50 MG / ML	SOLUTION · INTRAVENOUS; INTRAMUSCULAR	SANDOZ CANADA INCORPORATED
DIMENHYDRINATE INJECTION USP	00392731	10 MG / ML	SOLUTION · INTRAVENOUS	SANDOZ CANADA INCORPORATED
DIMENHYDRINATE INJECTION USP	02428954	50 MG / 1 ML	SOLUTION · INTRAVENOUS; INTRAMUSCULAR	HIKMA CANADA LIMITED
DIMENHYDRINATE INJECTION USP	02435241	250 MG / 5 ML	SOLUTION · INTRAVENOUS; INTRAMUSCULAR	HIKMA CANADA LIMITED
DIMENHYDRINATE INJECTION USP	02536536	50 MG / ML	SOLUTION · INTRAVENOUS; INTRAMUSCULAR	SANDOZ CANADA INCORPORATED
GAVISCON NAUSEA	02490528	50 MG	TABLET · ORAL	MEDTECH PRODUCTS INC
GRAVOL CHEWABLES	02384132	50 MG	TABLET (CHEWABLE) · ORAL	CHURCH & DWIGHT CANADA CORP
GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS	02254409	100 MG	TABLET (COMBINED RELEASE) · ORAL	CHURCH & DWIGHT CANADA CORP
GRAVOL LIQUID GELS	02245867	50 MG	CAPSULE · ORAL	CHURCH & DWIGHT CANADA CORP
GRAVOL SUPPOSITORIES	00013609	100 MG	SUPPOSITORY · RECTAL	CHURCH & DWIGHT CANADA CORP
GRAVOL TABLETS	00013803	50 MG	TABLET · ORAL	CHURCH & DWIGHT CANADA CORP
JAMP-DIMENHYDRINATE	02245416	50 MG	TABLET · ORAL	JAMP PHARMA CORPORATION
KIDS GRAVOL CHEWABLES	02384116	15 MG	TABLET (CHEWABLE) · ORAL	CHURCH & DWIGHT CANADA CORP
KIDS GRAVOL LIQUID	00230197	15 MG / 5 ML	SYRUP · ORAL	CHURCH & DWIGHT CANADA CORP
KIDS GRAVOL SUPPOSITORIES	00783595	25 MG	SUPPOSITORY · RECTAL	CHURCH & DWIGHT CANADA CORP
TRAVEL TABS 50 MG	00605786	50 MG	TABLET · ORAL	VITA HEALTH PRODUCTS INC

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.